Ear disorders and Neurologic disorders
Tinnitus
Definition: Tinnitus is often not a disease itself but a symptom caused by other underlying issues.
Common Causes:
Ototoxic medications
Possible factors affecting tinnitus include environmental and metabolic contributors.
Ototoxic Medications
Importance of Awareness: Health practitioners must educate patients about medications that can cause tinnitus.
Key Ototoxic Medications:
Lasix (Furosemide): A loop diuretic that can cause ototoxicity.
Aspirin: Commonly known, associated with tinnitus when taken in high doses.
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): All NSAIDs listed are ototoxic, including:
Ketorolac (Toradol)
Calcium Channel Blocker:
Nifedipine: Prescribed for hypertension.
Antibiotics:
Mycins: Such as gentamicin, clindamycin, erythromycin which can lead to ototoxicity.
Advice for Patients:
If taking these medications, report any ringing or buzzing in ears immediately to prevent permanent tinnitus.
Risk Factors for Ototoxicity
Increased Risk in Older Patients:
Metabolism Decrease: As individuals age, their bodies can't metabolize medications as efficiently.
Monitoring Meds: Importance of peak and trough testing for medications to monitor drug levels before the next dose.
Peak: Highest concentration in the blood.
Trough: Indicator of how well the medication is being metabolized prior to the next administration.
Benign Paroxysmal Positional Vertigo (BPPV)
Definition: A condition characterized by vertigo that occurs with specific changes in head position.
Etiology:
Caused by dislodged otoconia (little calcium carbonate crystals) within the inner ear.
Symptoms:
Incapacitating vertigo akin to being spun around and then stopping.
Clinical Manifestations:
Ataxia
Nystagmus (involuntary eye movement)
Vertigo (spinning sensation)
Diagnostic Test:
Dix-Hallpike Maneuver: Used to elicit symptoms and diagnose BPPV by moving the patient into positions that cause the otoconia to float.
Management:
Epley Maneuver: Repositioning to help settle otoconia back in place; patients must remain upright for 48 to 72 hours post-procedure.
Acoustic Neuroma
Definition: A benign tumor on the vestibulocochlear nerve (cranial nerve VIII) affecting hearing and balance.
Management:
Surgical removal of the tumor if symptomatic.
Neuro Disorders Overview
Resources: Medication guide provided through Blackboard, detailing medications for various neuro disorders.
Key Neuro Disorders Covered:
Multiple Sclerosis (MS)
Parkinson's Disease
Alzheimer’s Disease
Bacterial and Viral Meningitis
Multiple Sclerosis (MS)
Definition: An autoimmune disease characterized by the degeneration of myelin sheaths around neurons.
Risk Factors: Early onset often between 20-30 years, more common in females, linked to high stress periods.
Types of MS:
Relapsing-Remitting MS (RRMS): 85-90% of cases, characterized by flare-ups and returns to baseline status.
Secondary Progressive MS: Begins as RRMS and gradually worsens without distinct flare-ups.
Primary Progressive MS: Gradually worsens from onset without flare-ups.
Progressive Relapsing MS: Progressive worsening with occasional acute flare-ups.
Common Symptoms:
Fatigue, muscle spasms, cognitive impairments, bowel and bladder dysfunction.
Parisian depression and various sensory issues (vision changes, pain).
Nursing Management Goals:
Treat acute exacerbations, manage chronic symptoms, and provide patient education for long-term care.
Medications:
Disease-modifying therapies (administered via injection or IV).
Corticosteroids for managing acute exacerbations (methylprednisolone).
Parkinson's Disease
Definition: A neurodegenerative disorder with a primary decrease in dopamine levels.
Clinical Manifestations:
TRAP acronym: Tremors, Rigidity, Akinesia (bradykinesia), Postural instability.
Distinctive ‘shuffling gait’ and ‘cogwheeling’ stiffness during motion.
Management:
Levodopa and Carbidopa: Medications to manage dopamine levels.
Physical therapy to enhance mobility.
Surgical Options:
Deep brain stimulation as an invasive option for management.
Alzheimer's Disease
Definition: A progressive neurodegenerative disorder marked by cognitive decline.
Pathophysiology: Characterized by the presence of amyloid plaques and neurofibrillary tangles in the brain.
Clinical Manifestations:
Five A’s: Amnesia, Aphasia, Agnosia, Apraxia, and Anomia.
Early confusion and aggression with progressive loss of independent function.
Management Strategies:
Non-reversible treatments aimed at slowing decline, mainly through cholinesterase inhibitors (donepezil).
Nursing Interventions: Structure, routine, calm environment, and caregiver support essential to maintain patient dignity and provide quality care.